E21.1
Secondary hyperparathyroidism, not elsewhere classified
Clinical Classification Guidelines
Excludes Type 1
- secondary hyperparathyroidism of renal origin (N25.81)
Medical Intelligence & Overview
Secondary hyperparathyroidism is a condition characterized by the excessive production of parathyroid hormone (PTH) due to chronic low calcium levels, often as a response to other health issues involving the kidneys or calcium and vitamin D imbalance. This condition can lead to significant changes in bone health and metabolic processes. Recognized under ICD-10 code E21.1, it is distinct from primary hyperparathyroidism, which originates from the parathyroid glands themselves.
Causes & Symptoms
Clinical Causes: Chronic kidney disease (most common cause) Vitamin D deficiency or resistance Chronic malabsorption syndromes Early stages of severe liver disease Retention of phosphate in kidney failure Use of certain medications such as phenytoin or bisphosphonates Long-term dialysis treatment
Key Symptoms: Bone pain and fragility (osteomalacia) Muscle weakness Fatigue Itching (pruritus) Soft tissue calcifications Presence of kidney stones Altered mental status in severe cases Symptoms related to underlying condition, such as anemia in kidney disease
Diagnostic & Treatment
Diagnosis Path: Blood tests showing elevated levels of parathyroid hormone (PTH) Serum calcium levels often low or normal, sometimes elevated in advanced cases Serum phosphate levels elevated Vitamin D levels assessed Bone mineral density scans (DEXA scans) to evaluate bone health Imaging studies such as ultrasound or sestamibi scans to evaluate parathyroid glands in certain cases Evaluation of kidney function through serum creatinine and estimated glomerular filtration rate (eGFR)
Treatment Protocols: Addressing underlying causes, especially managing chronic kidney disease Use of vitamin D analogs (e.g., calcitriol) to help normalize calcium and PTH levels Phosphate binders to reduce serum phosphate levels Dietary management to control calcium and phosphate intake Monitoring and adjusting medications that affect calcium or PTH levels Dialysis in patients with end-stage renal disease Surgical removal of parathyroid glands (parathyroidectomy) in severe, refractory cases Management of associated bone disease and mineral metabolism
Clinical Advice & FAQs
Billing Guidance
Is E21.1 a billable ICD-10 code?
Yes, E21.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E21.1?
Clinical documentation must specify the nature of Secondary hyperparathyroidism, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference